Under the umbrella of Health Innovation Manchester (HInM), the city region is aligning its clinical research assets and infrastructure through a ‘One Manchester’ approach. This approach, relying on the collaborative and inter-organisational development and use of regional research facilities and joint applications for key research funding streams, is enabling Manchester to tackle regional health problems more effectively, and develop as a world-leading location for clinical trials. Along with Manchester’s clinical research facilities and the Greater Manchester Research Hub, MAHSC-CTU is one of the key assets helping to make this vision a reality. Currently, MAHSC-CTU is undertaking a programme of expansion. The aim is to provide, on a single central site on the university campus, critical mass and cross-discipline collaboration to improve the unit’s visibility and identity for collaborators. MAHSC-CTU will provide the latest cutting-edge methodologies for investigators and support for the design and costing of trials, randomisation, data management and research governance.
MAHSC-CTU is fully registered by the UKCRC and receives core funding from MAHSC partners. The unit also receives
National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.